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Increased concentrations of circulating insulin-like growth factor-I (IGF-I) or IGF-I relative to IGF-binding proteins (IGFBPs)
are associated with increased risk of developing several forms of cancer. Conversely, exercise is linked with reduced risk. This
study aims to investigate the eﬀect of a low-intensity exercise program on circulating levels of IGF-I, IGFBP-1, and IGFBP-3,
in previously sedentary males. Fourteen healthy men participated in cycle ergometer training at lactate threshold intensity for
60min/day, 5 days/week for 6 weeks. After aerobic training, insulin sensitivity improved by 20%, while fasting insulin levels
decreased by 13%. Simultaneously, low-intensity aerobic training decreased the circulating levels of IGF-I by 9%, while IGFBP-1
levelsincreasedby16%.AninterestingﬁndingwasthathigherpretraininglevelofIGF-IwasassociatedwithgreaterdeclineinIGF-
I with training. Insulin-sensitizing low-intensity aerobic exercise is thus considered to be an eﬀective method for downregulating
IGF-I and upregulating IGFBP-1 levels.
1.Introduction
Strong epidemiological evidence indicates that a sedentary
lifestyle leads to an increased risk of developing certain
cancers, including colon, prostate, breast, and endometrial
cancers [1–3]. By contrast, physical activity has been shown
to have a protective eﬀect against their development. IGF-
I is a potent mitogen that promotes cellular proliferation
and prevents apoptosis in normal and cancer cells [4–6].
IGF-I axis hormones are important factors implicated in the
beneﬁcial inﬂuence of exercise. Epidemiological studies have
shown that increased levels of circulating IGF-I or increased
IGF-I relative to IGFBP-3 are associated with a higher risk
of developing several forms of cancer, including prostate and
breast cancers [7–12].
Thecombinationofalow-fatdietandexerciseprogramis
known to reduce IGF levels. Barnard et al. [13, 14] showed a
decrease in the serum concentration of IGF-I and an increase
in IGFBP-1 with the implementation of a low-fat diet and
exercise program. Furthermore, they reported that serum
from men undergoing this form of intervention showed
reduced cancer cell growth and increased apoptosis in
LNCaP prostate cancer cells in vitro [13, 15]. In conjunction
with the changes in serum IGF-I and IGFBP-1, reductions
have also been shown in insulin and free testosterone, along
with increases in sex hormone-binding globulin [15, 16].
The changes in IGF-I and IGFBP-1 appear to be particularly
important. When IGFBP-1 was added to preintervention
serum, LNCaP cancer cells underwent apoptosis; whereas,
when IGF-I was added to postintervention serum, the2 International Journal of Endocrinology
reduction in growth was eliminated [17]. Thus, the down-
regulation of IGF-I and up-regulation of IGFBP-1, as a result
of the diet modiﬁcation and exercise intervention program,
m a yh a v ep r o t e c t i v ee ﬀects against the development of can-
cerous cells. However, the training intensity and/or duration
of exercise required to induce such favorable alterations has
not yet been fully elucidated.
A number of intervention studies have shown increased
[18–23], decreased [24, 25], or unaltered [26, 27]l e v e l s
of IGF-I after endurance or resistance training. Similarly,
many cross-sectional observational studies have examined
the association of physical activity with IGF-I levels in
the general population; however, their ﬁndings have been
inconsistent [28–32]. Additionally, some reports have shown
that circulating levels of IGFBP-1 and IGFBP-3 are also
modulated with exercise [23, 33, 34], whereas other groups
saw no eﬀects in their levels with moderate-intensity aerobic
exercise or strength training [35, 36]. The diﬀerent responses
of IGF axis hormones to the intensity and/or duration
of various types of exercise could be the reason why
exercise is not necessarily protective against all forms of
cancer. Furthermore, it also has been reported that very
heavy exercisers demonstrate high mortality ratios for lung,
colorectal, and pancreatic cancers [37].
Whether exercise induces desirable (i.e., downregulation
of IGF-I and upregulation of IGFBP-1) or undesirable (i.e.,
up-regulation of IGF-I and down-regulation of IGFBP-
1) eﬀects on cancer prevention is highly dependent on
training intensity. As high-intensity exercise produces an
acute increase in circulating IGF-I levels [38, 39], the exercise
intervention that induces a reduction in IGF-I levels may
be in the low or moderate categories. To the best of our
knowledge, only one cross-sectional study has shown a
reduction in serum IGF-I levels and increase in IGFBP-1
levelsinparticipantsofanexerciseprogram,withoutempha-
sis on diet modiﬁcation, in comparison to a control group
[16]. Despite the fact that physical exercise is considered
a strong intervention for cancer prevention [1], there are
few studies that speciﬁcally assess the eﬀects of exercise
on speciﬁc biomarkers of cancer [40]. In addition, it has
been described in a previous review that persons at varying
risks of developing cancer should be examined in exercise
intervention studies, as the magnitude of protection caused
by exercise may diﬀer in high-versus low-risk individuals
[40]. Furthermore, no previous intervention study has been
conducted to examine whether an exercise regimen alone
can elicit favorable changes in both IGF-I and IGFBP-1
levels for cancer prevention in healthy men. Additionally,
insulin is another factor which has the potential to inﬂuence
the levels of IGF-I and IGFBP-1 after exercise training.
Hyperinsulinemia stimulates liver production of IGF-I and
suppresses IGFBP-1 production [4, 41]. It is also known
that insulin itself promotes cellular growth in normal as
well as malignant tissues [42, 43]. In addition, leptin may
alsoregulatechangesinIGF-Ifollowingexerciseintervention
[44].
The lactate threshold (LT) represents the oxygen uptake
(VO2) or work rate above which there is a systemic rise in
blood lactate levels during incremental exercise [45]. The
LT level corresponds to approximately 50% VO2max,a n d
exercise at LT can be performed easily and safely even in the
elderly and individuals with metabolic syndrome [46, 47]. In
a previous study by our group, low-intensity aerobic training
at LT level caused an increase in insulin sensitivity (SI),
with a concomitant decrease in the basal level of insulin
[48]. In this study we used this exercise training program
as it was designed to have an insulin-sensitizing eﬀect. We
hypothesized that LT-level aerobic training, which does not
stimulate IGF-I production and reduces basal insulin levels,
would result in simultaneous alterations in both the down-
regulation of IGF-I and up-regulation of IGFBP-1. Thus,
we investigated the eﬀect of mild aerobic exercise training
at LT level on the circulating levels of IGF-I, IGFBP-1, and
IGFBP-3 to determine an optimal exercise intervention that
can induce favorable changes in IGF-I and IGFBP-1 levels for
cancer prevention in healthy men.
2. Methods
2.1. Subjects. Fourteen healthy men (22.6 ± 0.5 years) who
had not undergone any regular exercise for at least 2 years
were examined. All subjects were nonsmokers, had no
evidenceofchronicdisease,suchasdiabetes,hypertensionor
cancer,andwerenottakinganymedication.Allsubjectswere
also asked to maintain their normal dietary habits and not to
engage in any strenuous physical activity. Before beginning
the study, the nature, purpose, and risks of the study were
explained to all subjects, and informed written consent was
obtained. The protocol was approved by the local ethical
committee of Fukuoka University.
2.2.BodyComposition,PhysicalFitness,andExerciseTraining.
E a c hs u b j e c t ’ sb o d yf a tp e r c e n t a g ew a sm e a s u r e db yh y d r o -
static weighing before commencing training and 2 days after
the last training session. This was estimated based on the
hydrostatic density with a correction for the residual lung
volume. To measure physical ﬁtness, a graded exercise test
wasperformedon amechanicallybraked ergometer(Electric
Bicycle Ergometer, Lode’s Instrumenten B. V., Groningen,
Holland) before commencing the training program and 2
days after the ﬁnal training session. The work rate was
initially set at 10 watts and increased every 4 seconds by
1 watt, until physical exhaustion. VO2 was measured from
the mixed expired gas collected in neoprene bags. The
volume of the expired gas was quantiﬁed with a twin-drum-
type respirometer (Fukuda Irika CR-20, Tokyo, Japan),
and both the O2 and CO2 fractions were analyzed by a
mass spectrometer (ARCO-1000, ARCO System Inc., Chiba,
Japan). Blood samples were obtained from the earlobe every
30 seconds to measure blood lactate levels. The blood lactate
concentration was plotted against the exercise workload for
each subject, and the workload at the ﬁrst breaking of lactate
was used to calculate the exercise training intensity for each
subject. The LT was determined for each subject based on
a visual inspection, according to the estimations of three
experts, who were blinded to the purpose of our study, and
the average was used to establish the exercise intensity forInternational Journal of Endocrinology 3
Table 1: Characteristics of the subjects.
Before training After training
Age (year) 22.6 ± 0.5
Height (m) 1.71 ± 0.01
Weight (kg) 63.5 ± 1.8 62.9 ± 1.8
BMI (kg/m2) 21.7 ± 0.6 21.4 ± 0.6
Percent fat (%) 13.6 ± 1.1 12.9 ± 1.1
Fat mass (kg) 8.7 ± 0.9 8.2 ± 0.8
LBM (kg) 54.8 ± 1.4 54.7 ± 1.5
VO2max(mL/kg/min) 42.7 ± 1.1 45.4 ± 1.0
∗
LT-VO2 (mL/kg/min) 18.1 ± 0.9 23.5 ± 0.7
∗
Values are the means ± SE. BMI, body mass index; LBM, lean body mass;
LT-VO2,V O 2 at lactate threshold. ∗P< . 05 versus before training.
training. Cycle ergometer aerobic training at the LT level was
performed at our laboratory for 60 minutes per day, ﬁve
times a week for 6 weeks.
2.3. Blood Sampling and Analysis. Blood samples were
obtained from an antecubital vein each morning between
0700 and 0900h, following overnight fasting, prior to
training, and 16−72 hours after the ﬁnal training session.
Plasma glucose levels were measured spectrophotometrically
using glucose oxidase (Glucose B-test; Wako Pure Chemical,
Osaka, Japan); serum insulin (Phadeseph insulin radioim-
munoassay kit, Shionogi, Osaka, Japan) and leptin (Human
leptin kit, LINCO Research, Missouri, USA) concentrations
were measured by radioimmunoassay; and serum IGF-
I (Somatomedin-C·II [Chiron] measurement kit, Chiron
Inc., Tokyo, Japan), IGFBP-1 (DSL-7800, Diagnostic Systems
Laboratories, Inc., Texas, USA), and IGFBP-3 (Ab Tube IGF-
BP-3 Eiken, Diagnostic Systems Laboratories, Inc., Texas,
USA) were measured by immunoradiometric assay. The
intra- and interassay coeﬃcient variations were 3.9% and
2.8% for IGF-I, 4.6% and 6.0% for IGFBP-1, and 7.2%
and 10.5% for IGFBP-3, respectively. Pre- and posttraining
samples were measured simultaneously. Insulin resistance
index (IRI) was calculated using Matthews’ formula [49].
2.4. Intravenous Glucose Tolerance Test (IVGTT) and Min-
imal Model Data Analysis. IVGTTs were performed before
commencing the training program and 16 hours after the
last training session. Following overnight fasting, subjects
were allowed to rest while lying down for at least 30 minutes
prior to blood sampling. Baseline samples for glucose and
insulin were obtained, followed by glucose administration
via the contralateral antecubital vein (300mg/kg body
weight)within2minutes.Subsequentsampleswereobtained
at frequent intervals until 180min, as previously described
[50]. Insulin (Humalin; Shionogi, Osaka, Japan) was infused
(20mU/kg) via an antecubital vein between the periods
of 20−25 minutes post glucose administration. On the day
before undergoing IVGTT, all subjects were provided with
an evening meal consisting of ≥140g carbohydrate, ≥30g
fat, and ≥33g protein. SI was estimated using a minimal
model approach, as previously described [50]. The SI index
Table 2: Metabolic parameters: IGF-I, IGFBP-1, and, IGFB-3
before and after mild training.
Before training After training
n 14 14
Basal glucose (mg/dL) 93.0 ± 1.0 90.3 ± 1.3
∗
Basal insulin (μU/mL) 4.7 ± 0.2 4.1 ± 0.2
∗
IRI (μU·mL
−1·mg·dL
−1)1 . 0 8 ± 0.06 0.91 ± 0.05
∗
SI (×10
−5·min·μU·mL
−1) 16.2 ± 1.5 19.5 ± 1.4
∗
Leptin (ng/mL) 1.9 ± 0.3 1.7 ± 0.1
IGF-I (ng/mL) 245 ± 28 223 ± 22
∗
IGFBP-1 (ng/mL) 39.4 ± 2.8 45.7 ± 3.8
∗
IGFBP-3 (ng/mL) 2665 ± 129 2583 ± 110
Values are the means ± SE. IRI, insulin resistance index; SI, insulin
sensitivity;IGF-I,insulin-likegrowthfactor-I;IGFBP,IGF-bindingprotein.
∗P<. 05 versus before training.
represents the net increase in glucose disappearance rate,
which also depends on the rise in insulin above basal
levels. The minimal model program was written using Pascal
programming (Borland International, CA) on a Macintosh
IIcx (Apple Computer, CA).
2.5. Statistics. All values are shown as the means ± stan-
dard error (SE). Statistical analyses were performed using
Wilcoxon’s signed-rank test. Pearson’s correlation coeﬃcient
was used for the analysis of the correlation between the
changes of variables after the exercise training. A P value of
less than .05 was considered to be statistically signiﬁcant.
3. Results
Weight and body fat percentage did not change after
the training period (Table 1). By contrast, mild training
signiﬁcantly increased indices of aerobic ﬁtness. Both basal
glucose and insulin levels signiﬁcantly reduced after train-
ing (Table 2). Although IRI, which was calculated using
Matthews’ formula, increased only slightly, the increase was
signiﬁcant. Circulating leptin levels were not inﬂuenced by
training. LT exercise was found to signiﬁcantly decrease the
circulating levels of IGF-I, whereas IGFBP-1 was signiﬁcantly
increased.Bycontrast,IGFBP-3levelswerenotinﬂuencedby
training.
There was no signiﬁcant relationship between the base-
line level of IGF-I and baseline measures of VO2max (r =
0.15) or LT-VO2 (r = 0.20). There were also no signiﬁcant
correlations between the change in circulating IGF-I levels
and the changes in aerobic ﬁtness (VO2max, r =− 0.10),
basal insulin (r = 0.08), IRI (r = 0.12), and SI (r = 0.41)
after exercise intervention. Similarly, relationships between
the change in IGFBP-1 and changes in basal insulin (r =
−0.33) and SI (r = 0.27) were not statistically signiﬁcant.
Furthermore, the change in leptin levels after exercise was
not signiﬁcantly correlated with the changes in IGF-I (r =
−0.22) or IGFBP-1 (r =− 0.45). Conversely, there was a
negative correlation between pre-training IGF-I levels and
individual changes in IGF-I after training (r =− 0.77;4 International Journal of Endocrinology
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Figure 1: Relationship between pre-training IGF-I level and
individual changes in IGF-I after training.
10 8 6 4 2 0 −2 −4
Change in VO2max(mL/kg/min)
−10
0
10
20
30
C
h
a
n
g
e
i
n
I
G
F
B
P
-
1
(
n
g
/
m
L
)
Figure 2: Changes in VO2max and circulating IGFBP-1 levels after
low-intensity exercise.
P< . 01) (Figure 1). Changes in VO2max showed a positive
correlation with changes in IGFBP-1 (r = 0.61; P< . 05)
(Figure 2).
4. Discussion
The main ﬁndings of this study were as follows: (1)
short-term cycle ergometer aerobic training at LT level
decreases circulating IGF-I concentrations and increases
IGFBP-1 levels, without changing body weight, in previously
sedentary men; (2) there is an inverse relationship between
pre-training IGF-I levels and individual changes in IGF-I
after training, suggesting that individuals with a higher pre-
training IGF-I level will have a more substantial decrease in
IGF-I following exercise intervention; and (3) increases in
aerobic ﬁtness (VO2max) positively correlates with changes
in IGFBP-1 level after training. It is known that alterations
in the IGF axis, including a reduction in IGF-I and an
increase in IGFBP-1, by lifestyle modiﬁcation are associated
with an in vitro r e d u c t i o ni np r o s t a t ec a n c e rc e l l( L N C a P )
growth and increased apoptosis [13, 16]. Thus, the current
insulin-sensitizing exercise program is a safe and easily-
performed exercise program that simultaneously induces a
down-regulation of IGF-I and up-regulation of IGFBP-1.
The physiological eﬀects of decreased IGF-I and
increased IGFBP-1 levels after mild aerobic training have
not been clariﬁed by this study. However, since IGF-
I infusion causes hypoglycemia, primarly by stimulating
peripheral glucose uptake [51], and IGFBPs buﬀer the
acute hypoglycemic eﬀect of IGF-I [52], we thus speculate
that the alterations in IGF-I and IGFBP-1 levels may be
an adaptive response to prevent hypoglycemia following
insulin-sensitizing training. In a previous study of exercise-
induced energy deﬁcit, leptin administration signiﬁcantly
increased circulating levels of IGF-I in healthy men and
women [44]. In this study, leptin levels were unchanged after
thetrainingprogram,andtheindividualchangesinthelevels
of IGF-I were not signiﬁcantly correlated with the changes in
leptin concentration. Thus, leptin may not play a role in the
alteration of IGF-I after mild exercise in healthy men.
The principal factor enhancing the production of IGF-
I in the liver is growth hormone, which stimulates IGF-I
synthesis and is further enhanced by insulin [41, 52]. As
fasting insulin levels are slightly but signiﬁcantly decreased
after exercise intervention, it could potentially contribute to
the reduction in IGF-I levels. Some [19, 22, 39], but not all
[53–55], previous studies have reported increases in IGF-
I after acute exercise; however, these increases are transient
and typically return to baseline levels within 10−15min after
exercise [56]. Increases in IGF-I after acute exercise are
considered to be unrelated to exercise-induced increases in
growth hormone [56]. Moreover, increases in IGF-I after
a c u t ee x e r c i s ew e r eo b s e r v e di ng r o w t hh o r m o n e - d e ﬁ c i e n t
subjects [19]. We previously showed that acute bout of
exercise at LT transiently increases growth hormone level
[57]. However, it is likely that resting levels of growth
hormone are not inﬂuenced by low-intensity training [58].
It is worthwhile noting that this study examines changes
in systemic IGF-I levels and that changes in local production
(i.e., paracrine/autocrine eﬀects) are not assessed. Thus, this
studycouldnotcapturethepotentialeﬀectofexerciseonIGF
changes at the tissue level. A single bout of acute resistance
exercise upregulates local (i.e., skeletal muscle) IGF-I [59–
61]. To the best of our knowledge, whether local IGF-
I is upregulated by low-intensity aerobic exercise remains
unknown. A recent review suggested that local changes
in IGF-I are independent of changes in circulating IGF-I,
indicating that serum IGF-I is not necessarily a reﬂection of
local concentrations [56]. Thus, in this study, the reduced
levels of systemic IGF-I post-exercise intervention may not
have been inﬂuenced by local IGF-I.
It has been considered that reduced insulin levels after
exercise may contribute to the up-regulation of IGFBP-1
[14]. Furthermore, exercise-induced changes in basal insulin
levels did not signiﬁcantly correlate with changes in IGFBP-
1; however, this may be due to the low number of subjects.
Conversely,thepresentresultsshowasigniﬁcantrelationship
between changes in VO2max and circulating IGFBP-1 levels.
Additionally, it seems noteworthy that correlations betweenInternational Journal of Endocrinology 5
the change in IGFBP-1 and changes in basal insulin (r =
−0.33) and SI (r = 0.27) were moderate and in the
expected direction, although not statistically signiﬁcant. The
lack of statistical signiﬁcance is most likely due to the
low sample size. Although we are unable to explain the
underlying mechanisms, the enhancement of aerobic ﬁtness
might be important in the up-regulation of IGFBP-1 with
low-intensity training. It was shown by Hellenius et al. [62]
that low-intensity aerobic exercise (2 to 3 times/week at an
intensity of 60−80% maximal heart rate for 30−45min) for
6 months improved SI and increased IGFBP-1 in healthy
middle-aged men. Although that study did not assess the
level of aerobic ﬁtness (VO2max), fasting insulin levels
decreased in the exercise group by 14%, with a 15% increase
inIGFBP-1aftertrainingfor6months.Inthisstudyasimilar
decrease in fasting insulin (13%) caused a similar increase
in IGFBP-1 (16%) after exercise intervention. This indicates
that increases in IGFBP-1 are regulated by changes in insulin
induced by exercise training.
A previous study showed that the changes in IGF-I
and IGFBP-1 levels, induced by a combined low-fat diet
and exercise program, were accompanied by a reduction in
body weight [16]. Furthermore, in this cross-sectional study,
participants in the exercise program with a lower IGF-I and
higher IGFBP-1 had a much lower BMI, compared with
the control group [16]. By contrast, another report on the
eﬀects of aerobic exercise combined with a low-fat, high-
complex carbohydrate diet showed reduced serum insulin
and positive control over aspects of metabolic syndrome,
including hypertension and hypertriglyceridemia, over a
period of only 3 weeks, even though the subjects remained
overweight or obese [63]. Furthermore, using regression
analyses, Nemet et al. [64] examined IGF-I and body mass
changes associated with 7-day strenuous exercise and found
a decrease in IGF-I levels, even in weight-stable subjects.
Similarly, this study showed that alterations of circulating
IGF-I and IGFBP-1, basal insulin, and SI after LT-level
training were observed without changes in body weight and
body fat percentage. Thus, in conjunction with previous
results, this suggests the importance of exercise alone, rather
than changes in body composition, on the regulation of IGF-
I and IGFBP-1.
There were some limitations of this study that should
also be described. The short period (6 weeks) of training
intervention was a limiting factor in this study. Further
studies are needed to examine whether longer periods of
exercise intervention induce sustained and greater impacts
onthechangesininsulinsensitivity,fastinginsulin,andIGF-
I and IGFBP-1 levels. Information on dietary intake before
and during the intervention was not recorded, despite the
fact that diet is an important modiﬁer of IGF levels. Because
of this limitation, we are unable to perform a cross-sectional
analysis of the relationship between dietary components and
IGF levels. It is already known that IGF-I declines during
energy and protein restriction [41]. Since body weight did
not decrease in this study, dietary intake does not need to be
reduced during the exercise intervention. Thus, reduced IGF
levels after the current aerobic training might not be aﬀected
by decreased dietary intake. Another limitation is that this
study has no control group. The potential problems with the
absence of a control group are the unwitting incorporation
of a sampling bias. For example, the possibility that an
inverserelationshipbetweentheinitial(baseline)IGF-Ilevels
and the change in IGF-I levels after training could be due
to a convergence towards the mean eﬀect cannot be fully
excluded.However,previousreportshaveshownthatasingle
IGF-I measurement is generally representative of the levels
over a period of time [7] and IGF-I levels appear to have no
detectable diurnal or circadian variation [29, 65].
It is also worth mentioning that, although a lower level
of IGF-I is associated with a lower cancer risk in prospective
healthy population, several studies have shown that lower
IGF-I is associated with an increased risk of cardiovascular
disease, type II diabetes, obesity [56, 66], osteoporosis, and
cognitive decline [56]. There are also reports of conﬂicting
data showing that subjects with obesity or type II diabetes
have normal levels of total IGF-I [67, 68] and no signiﬁcant
correlation between IGF-I and bone mineral density in
women [69, 70]. Nindl and Pierce have described in their
recent review that the fact that there are studies claiming
that both increases and decreases in IGF-I concentrations
have beneﬁcial eﬀects on health presents a contradictory
situation. Furthermore, they also stated that, even though
local IGF-I is consistently up-regulated with both acute and
chronic exercises, circulating IGF-I may actually decrease
[56]. However, despite lowering IGF-I, the current exercise
program would be expected to have beneﬁcial eﬀects on all
of these various conditions.
In this study, subjects were healthy men with a relatively
low risk of developing cancer. Although the changes in IGF-
I were most dramatic in men with high baseline levels, it is
notclearwhetherthiswillapplytopopulationswithdiﬀerent
baseline levels. Serum levels of IGF-I are inversely associated
with age [29, 31], and IGF-I levels are higher in women
t h a ni nm e ni nW e s t e r np o p u l a t i o n[ 29]. Conversely, in the
Japanese population, the circulating IGF-I level was found
to be higher in men than in women [32]. Further work is
needed to extend the present outcome to a wider population
by examining whether the same exercise regimen at the LT
can induce such favorable changes in individuals who have
elevated IGF-I levels and are at increased risk of developing
cancer.
In conclusion, we found that short-term aerobic exer-
cisetraining at LT levels decreased circulating IGF-I and
increased IGFBP-1 levels, without changing body composi-
tion, in previously sedentary men. These results are consis-
tent with those of a previous rodent study demonstrating
the beneﬁcial eﬀects of low-level exercise on cardiovascular,
as well as cancer risk factors [71]. It has been described
that physical exercise deserves particular attention in the
prevention of neoplasia, especially as it also exerts consistent
beneﬁcial eﬀects on other major chronic diseases prevalent
in the Western world, such as atherosclerosis and type
2 diabetes [1]. The current low-intensity aerobic training
r e g i m e ni st h u sc o n s i d e r e dt ob ea ne ﬀective approach in
healthy men for down-regulating IGF-I and up-regulating
IGFBP-1 levels.6 International Journal of Endocrinology
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